Raymond J. Henley Iii

Array ( [id] => 5649747 [patent_doc_number] => 20060135482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Use of fosinopril to reduce cardiovascular events in disalysis patients' [patent_app_type] => utility [patent_app_number] => 10/534052 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3799 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20060135482.pdf [firstpage_image] =>[orig_patent_app_number] => 10534052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1034535 [patent_doc_number] => 06875745 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-05 [patent_title] => 'Method and composition for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 10/683199 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 7884 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/875/06875745.pdf [firstpage_image] =>[orig_patent_app_number] => 10683199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7612600 [patent_doc_number] => 06903235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-07 [patent_title] => 'Pharmaceutical-grade ferric citrate' [patent_app_type] => utility [patent_app_number] => 10/682045 [patent_app_country] => US [patent_app_date] => 2003-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2592 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/903/06903235.pdf [firstpage_image] =>[orig_patent_app_number] => 10682045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5777475 [patent_doc_number] => 20060106115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Osteogenesis promoter containing beta-cryptoxanthin as the active ingredient' [patent_app_type] => utility [patent_app_number] => 10/532775 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6814 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20060106115.pdf [firstpage_image] =>[orig_patent_app_number] => 10532775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7310675 [patent_doc_number] => 20040142961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Utilization of substituted imidazo[1,2-a]-pyridine compounds in pharmaceutical formulations' [patent_app_type] => new [patent_app_number] => 10/678645 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6705 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142961.pdf [firstpage_image] =>[orig_patent_app_number] => 10678645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 798022 [patent_doc_number] => 07427609 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-23 [patent_title] => 'Treatment of conditions relating to hormone deficiencies by administration of progestins' [patent_app_type] => utility [patent_app_number] => 10/678828 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5668 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/427/07427609.pdf [firstpage_image] =>[orig_patent_app_number] => 10678828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7207174 [patent_doc_number] => 20050043342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Methods for treating urinary incontinence and other disorders using trospium' [patent_app_type] => utility [patent_app_number] => 10/677527 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4317 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043342.pdf [firstpage_image] =>[orig_patent_app_number] => 10677527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225547 [patent_doc_number] => 20040072864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Method and composition for treatment of irritable bowel disease' [patent_app_type] => new [patent_app_number] => 10/673227 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11239 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072864.pdf [firstpage_image] =>[orig_patent_app_number] => 10673227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7455656 [patent_doc_number] => 20040068130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Methods and preparations of extracts of Uncaria species with reduced alkaloid content' [patent_app_type] => new [patent_app_number] => 10/674986 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2400 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20040068130.pdf [firstpage_image] =>[orig_patent_app_number] => 10674986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 758244 [patent_doc_number] => 07015248 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-21 [patent_title] => 'Use of abietic acid and derivatives thereof for inhibiting cancer' [patent_app_type] => utility [patent_app_number] => 10/672683 [patent_app_country] => US [patent_app_date] => 2003-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4751 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/015/07015248.pdf [firstpage_image] =>[orig_patent_app_number] => 10672683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474793 [patent_doc_number] => 20040097529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Novel use of arylethene sulfonamide derivative' [patent_app_type] => new [patent_app_number] => 10/472855 [patent_app_country] => US [patent_app_date] => 2003-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7495 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097529.pdf [firstpage_image] =>[orig_patent_app_number] => 10472855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7454187 [patent_doc_number] => 20040067995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Novel combination of a factor Xa inhibitor and clopidogrel' [patent_app_type] => new [patent_app_number] => 10/671285 [patent_app_country] => US [patent_app_date] => 2003-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6096 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067995.pdf [firstpage_image] =>[orig_patent_app_number] => 10671285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367980 [patent_doc_number] => 20040092530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Methods for treating neuropsychiatric disorders' [patent_app_type] => new [patent_app_number] => 10/668583 [patent_app_country] => US [patent_app_date] => 2003-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5132 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092530.pdf [firstpage_image] =>[orig_patent_app_number] => 10668583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7412192 [patent_doc_number] => 20040106671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Remedies for vesical hyperesthesia' [patent_app_type] => new [patent_app_number] => 10/472144 [patent_app_country] => US [patent_app_date] => 2003-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5508 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106671.pdf [firstpage_image] =>[orig_patent_app_number] => 10472144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7306250 [patent_doc_number] => 20040116451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Method of treatment' [patent_app_type] => new [patent_app_number] => 10/667119 [patent_app_country] => US [patent_app_date] => 2003-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1512 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116451.pdf [firstpage_image] =>[orig_patent_app_number] => 10667119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5881498 [patent_doc_number] => 20060030581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Mannitol formulation for integrin receptor antagonist' [patent_app_type] => utility [patent_app_number] => 10/527605 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3854 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20060030581.pdf [firstpage_image] =>[orig_patent_app_number] => 10527605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 623725 [patent_doc_number] => 07138433 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-21 [patent_title] => 'Quinone-based therapeutic agent for hepatopathy' [patent_app_type] => utility [patent_app_number] => 10/662820 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 3750 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/138/07138433.pdf [firstpage_image] =>[orig_patent_app_number] => 10662820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7337093 [patent_doc_number] => 20040132728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Combinations of atorvastatin and alpha1adrenergic receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/663082 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6457 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132728.pdf [firstpage_image] =>[orig_patent_app_number] => 10663082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7619993 [patent_doc_number] => 06943190 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-13 [patent_title] => 'Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions' [patent_app_type] => utility [patent_app_number] => 10/662975 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 17 [patent_no_of_words] => 7016 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/943/06943190.pdf [firstpage_image] =>[orig_patent_app_number] => 10662975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1002488 [patent_doc_number] => 06908943 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-21 [patent_title] => 'Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease' [patent_app_type] => utility [patent_app_number] => 10/660927 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14690 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/908/06908943.pdf [firstpage_image] =>[orig_patent_app_number] => 10660927 [rel_patent_id] =>[rel_patent_doc_number] =>)